Even as boom wanes, a new $200M SPAC is still hoping for another big score

The biotech sector has been booming throughout the Covid-19 pandemic — and while it has slowed down considerably, there are yet more SPACs at work.

Blank check company BioPlus Acquisition Corp announced last Thursday that it priced its upsized IPO of 20 million units at $10.00 per unit — for...

Click to view original post